The Pomp Podcast: Bitcoin, AI Agents, and Eli Lilly's Unexpected Edge

Bitcoin’s selloff may be less about panic and more about a market regime shift. In this full-length conversation distilled into a minutes-long recap, Anthony Pompliano and Jordi Visser unpack why Bitcoin is down, whether the classic four-year cycle still matters, and how AI agents, capital allocation, and volatility are reshaping markets. Visser makes a bold case that AI is accelerating commerce, turning Bitcoin into a bet on a world where agents outperform humans, while also arguing that the current chart setup points to a bear market until momentum changes. He then pivots from crypto to AI investing and biotech, explaining why Eli Lilly stands out thanks to proprietary data, real-world applications, and the promise of GLP-1 drugs in obesity, addiction, and health spending. If you’re following Bitcoin, AI regulation, automation, and the future of business and biotech, this episode ties the big themes together fast. Listen now to get the key ideas in minutes.